QUVU vs. EASG ETF Comparison
Comparison of Hartford Quality Value ETF (QUVU) to Xtrackers MSCI EAFE ESG Leaders Equity ETF (EASG)
QUVU
Hartford Quality Value ETF
QUVU Description
Under normal circumstances, the fund seeks to achieve its investment objective by investing primarily in common stocks of issuers located in the United States. The fund may invest in a broad range of market capitalizations, but tends to focus on large capitalization companies with market capitalizations similar to those of companies in the Russell 1000 Value Index.
Grade (RS Rating)
Last Trade
$26.85
Average Daily Volume
5,461
Number of Holdings
*
64
* may have additional holdings in another (foreign) market
EASG
Xtrackers MSCI EAFE ESG Leaders Equity ETF
EASG Description
The investment seeks investment results that correspond generally to the performance, before fees and expenses, of the MSCI EAFE ESG Leaders Index (the "underlying index"). The fund will invest at least 80% of its total assets (but typically far more) in component securities (including depositary receipts in respect of such securities) of the underlying index. The underlying index is a capitalization weighted index that provides exposure to companies with high environmental, social and governance ("ESG") performance relative to their sector peers. The fund is non-diversified.Grade (RS Rating)
Last Trade
$30.06
Average Daily Volume
2,594
Number of Holdings
*
16
* may have additional holdings in another (foreign) market
Performance
Period | QUVU | EASG |
---|---|---|
30 Days | 1.94% | -3.28% |
60 Days | 3.58% | -7.46% |
90 Days | 4.59% | -8.08% |
12 Months | 23.79% | 9.57% |
QUVU Overweight 62 Positions Relative to EASG
Symbol | Grade | Weight | |
---|---|---|---|
JPM | A | 3.9% | |
WFC | A | 3.43% | |
UNH | C | 3.41% | |
MS | A | 2.99% | |
PM | B | 2.8% | |
AXP | A | 2.69% | |
EOG | A | 2.25% | |
WMB | A | 2.19% | |
BAC | A | 2.18% | |
KNX | B | 2.1% | |
OMC | C | 2.09% | |
CSCO | B | 2.05% | |
MDT | D | 1.95% | |
CTSH | B | 1.88% | |
HON | B | 1.85% | |
CVX | A | 1.8% | |
ATO | A | 1.79% | |
PFE | D | 1.78% | |
AEP | D | 1.67% | |
LMT | D | 1.64% | |
MMC | B | 1.62% | |
DUK | C | 1.61% | |
PFG | D | 1.61% | |
AZN | D | 1.59% | |
SRE | A | 1.58% | |
TTE | F | 1.57% | |
ACN | C | 1.56% | |
QCOM | F | 1.51% | |
ELV | F | 1.45% | |
TXN | C | 1.38% | |
DIS | B | 1.37% | |
AMT | D | 1.32% | |
CMCSA | B | 1.31% | |
BDX | F | 1.3% | |
LKQ | D | 1.29% | |
WAB | B | 1.28% | |
CB | C | 1.27% | |
KDP | D | 1.26% | |
FMC | D | 1.26% | |
AIG | B | 1.24% | |
NXPI | D | 1.19% | |
ARMK | B | 1.19% | |
SPG | B | 1.14% | |
MRK | F | 1.12% | |
DAL | C | 1.1% | |
TSN | B | 1.06% | |
GOOGL | C | 0.98% | |
OTIS | C | 0.98% | |
AMCR | D | 0.96% | |
SYY | B | 0.91% | |
CTRA | B | 0.91% | |
PSA | D | 0.91% | |
TJX | A | 0.9% | |
BHP | F | 0.88% | |
HST | C | 0.83% | |
MDLZ | F | 0.82% | |
ROP | B | 0.76% | |
MET | A | 0.67% | |
KVUE | A | 0.65% | |
LOW | D | 0.59% | |
CE | F | 0.41% | |
GILD | C | 0.3% |
QUVU: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Banks - Global
Semiconductors
Diversified Industrials
Health Care Plans
Household & Personal Products
Information Technology Services
Insurance - Life
Oil & Gas E&P
Oil & Gas Integrated
Utilities - Regulated Electric
Advertising Agencies
Aerospace & Defense
Agricultural Inputs
Airlines
Apparel Stores
Auto Parts
Beverages - Soft Drinks
Capital Markets
Chemicals
EASG: Top Represented Industries & Keywords
Industries:
Drug Manufacturers - Major
Airports & Air Services
Banks - Global
Banks - Regional - Asia
Banks - Regional - Europe
Beverages - Soft Drinks
Capital Markets
Computer Systems
Consumer Electronics
Diagnostics & Research
Household & Personal Products
Information Technology Services
Software - Application
Keywords:
Asset Management
Banking
Advisory Services
Asset Management Services
Bank
Biotechnology
Cash Management
Cash Management Services
Commercial Banking
Exchange Traded Fund
Eye Care Products
Financial Advisory Services
Financial Products
Investment Banking
Investment Banking Services
Investment Product
Mitsui
Molecular Diagnostics
Pharmaceutical
Securitization